Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Public ClinicalTrials.gov record NCT07363577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia
Study identification
- NCT ID
- NCT07363577
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- LB Pharmaceuticals Inc.
- Industry
- Enrollment
- 456 participants
Conditions and interventions
Conditions
Interventions
- LB-102 (100 mg tablet) Drug
- LB-102 (50 mg tablet) Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2026
- Primary completion
- May 31, 2027
- Completion
- Sep 30, 2027
- Last update posted
- May 5, 2026
2026 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pillar Clinical Research | Bentonville | Arkansas | 72712 | Recruiting |
| Pillar Clinical Research | Little Rock | Arkansas | 72204 | Recruiting |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | Recruiting |
| ProScience Research Group | Culver City | California | 90230 | Recruiting |
| CenExel | Garden Grove | California | 92845 | Recruiting |
| Synergy San Diego | Lemon Grove | California | 92064 | Recruiting |
| Clinical Innovations, Inc. | Riverside | California | 92506 | Recruiting |
| Health Synergy Clinical Research | Boynton Beach | Florida | 33426 | Recruiting |
| Innovative Clinical Research | Miami Lakes | Florida | 33016 | Recruiting |
| Accelerated Clinical Trial | Snellville | Georgia | 30078 | Recruiting |
| Pillar Clinical Research | Chicago | Illinois | 60641 | Recruiting |
| Arch Clinical Trials | St Louis | Missouri | 63141 | Recruiting |
| Neuro-Behavioral Clinical Research | North Canton | Ohio | 44720 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07363577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07363577 live on ClinicalTrials.gov.